Ideas to Action:

Independent research for global prosperity

CGD Policy Blogs

 

Access to ARVs: Need, Targets & Markets

UNAIDS prevalence estimates formed the basis of the missed "3 by 5" target, and so the news that they were so highly inflated is particularly timely coming on the heels of the WHO report on the initiative, which (among other things) illustrates the perverse relationship between disease estimates, advocacy targets and pharmaceutical markets.

Access to ARVs: Need, Targets & Markets

UNAIDS prevalence estimates formed the basis of the missed "3 by 5" target, and so the news that they were so highly inflated is particularly timely coming on the heels of the WHO report on the initiative, which (among other things) illustrates the perverse relationship between disease estimates, advocacy targets and pharmaceutical markets.

Why Numbers Matter & What Went Wrong

In a recent article, How AIDS in Africa Was Overstated, Washington Post correspondent Craig Timberg presents evidence that global HIV/AIDS rates have been systematically overestimated by UNAIDS based on the long-held (and erroneous) assumption that infection rates among pregnant women attending antenatal clinics can serve as a rough proxy of the general adult prevalence in that country.

Why Numbers Matter & What Went Wrong

In a recent article, How AIDS in Africa Was Overstated, Washington Post correspondent Craig Timberg presents evidence that global HIV/AIDS rates have been systematically overestimated by UNAIDS based on the long-held (and erroneous) assumption that infection rates among pregnant women attending antenatal clinics can serve as a rough proxy of the general adult prevalence in that country.

Recent News Roundup

As you can tell, we've been pretty busy these past few weeks while we've moved over to the new Global Health Policy blog. In the process, we missed some news and links worth mentioning here, albeit belatedly:

Vaccines

  • Adel Mahmoud (former president of Merck Vaccines) was named president of the Global HIV Vaccine Enterprise

Pages